SRAM
XENT

Stone Ridge Asset Management’s Intersect ENT, Inc XENT Stock Holding History

Stone Ridge Asset Management’s Portfolio XENT Stock Details XENT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-8,374
Closed -$236K – 1274
2018
Q4 		$236K Hold
8,374
– – 0.01% 1078
2018
Q3 		$241K Sell
8,374
-900
-10% -$27K 0.01% 1122
2018
Q2 		$347K Hold
9,274
– – 0.02% 952
2018
Q1 		$364K Hold
9,274
– – 0.02% 951
2017
Q4 		$300K Buy
+9,274
New +$278K 0.02% 1060

Other funds holding XENT

HM
HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

Stone Ridge Asset Management's XENT Position: Q1 2019 in Review

Stone Ridge Asset Management sold out of Intersect ENT, Inc (XENT) in Q1 2019, closing a stake of 8,374 shares — an estimated $236K sold.

Stone Ridge Asset Management first reported a position in XENT in Q4 2017 and held it in 5 quarters. The position peaked at $364K in Q1 2018. 136 funds tracked by Wall St. Rank hold XENT as of Q1 2019.

  • Stone Ridge Asset Management reported no remaining Intersect ENT, Inc position as of Q1 2019 after selling out during the quarter.
  • Stone Ridge Asset Management sold 8,374 Intersect ENT, Inc shares in Q1 2019, an estimated $236K.
  • Stone Ridge Asset Management first reported a position in Intersect ENT, Inc in Q4 2017 and held it in 5 quarters.
  • Stone Ridge Asset Management's Intersect ENT, Inc position peaked at $364K in Q1 2018.
  • 136 funds tracked by Wall St. Rank held Intersect ENT, Inc as of Q1 2019.

Based on Stone Ridge Asset Management's 13F filing for Q1 2019, filed 14 May 2019.